Pliant Therapeutics Inc

Market Cap

$74M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.15-$0.10 (-8.00%)

Jun 5, 2026

52W High $1.8752W Low $1.09

Company Details

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, sma...

CEO

—

IPO Date

Jun 3, 2020

Website

pliantrx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$113M

EPS (Diluted)

Free Cash Flow

-$99M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 11, 2026

FY 2025

Mar 11, 2026

Q4 2025

Mar 11, 2026

$0-100.0%

Q3 2025

Nov 6, 2025

Q2 2025

Aug 7, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee